Newsletter Volume 2

March 2021

Learn more about MDGH's plans for its new investigational treatment for tuberculosis and leprosy types 2 reactions.

March 2021

Learn more about MDGH's plans for its new investigational treatment for tuberculosis and leprosy types 2 reactions.

View HTML newsletter

Stay up to date

Follow our work by signing up for our newsletter

Thank you, your submission has been received.

Oops! Something went wrong while submitting the form.

Navigate to

Affiliate websites

Get in touch

MDGH respectfully acknowledges the Traditional Owners of the land on which our office is located, the Wurundjeri people of the Kulin Nation, and pay our respect to their Elders past, present and emerging.

Medicines Development for Global Health Limited.
Level 1, 18 Kavanagh Street Southbank Victoria 3006 Australia.
ABN: 79 116 977 523